Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study)

Published:2023 Issue: Volume:37 Page:100772
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Antolín Novoa Silvia,Escrivá-de-Romaní Santiago,Tolosa Ortega Pablo,Oliva Fernández Lucía,López López Rafael,López González Ana,de la Morena Barrio Pilar,Echavarria Díaz-Guardamino Isabel,Alés Martinez José Enrique,Garate Zita,González-Cortijo Lucia

Funder

Roche

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Gene expression and miRNAs profiling: function and regulation in human epidermal growth factor receptor 2 (HER2)-positive breast cancer;Sareyeldin;Cancers (Basel),2019

3. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience;Chen;J. Clin. Oncol.,2004

4. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database;Killelea;J. Am. Coll. Surg.,2015

5. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP